D.E. Shaw & Co’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191K | Sell |
25,329
-6,165
| -20% | -$46.4K | ﹤0.01% | 2841 |
|
|
2025
Q1 | $238K | Sell |
31,494
-17,438
| -36% | -$132K | ﹤0.01% | 2719 |
|
|
2024
Q4 | $596K | Sell |
48,932
-10,308
| -17% | -$126K | ﹤0.01% | 2325 |
|
|
2024
Q3 | $992K | Sell |
59,240
-153,208
| -72% | -$2.56M | ﹤0.01% | 2174 |
|
|
2024
Q2 | $3.71M | Buy |
212,448
+150,827
| +245% | +$2.63M | ﹤0.01% | 1420 |
|
|
2024
Q1 | $1.05M | Buy |
61,621
+12,702
| +26% | +$216K | ﹤0.01% | 2088 |
|
|
2023
Q4 | $498K | Buy |
48,919
+9,217
| +23% | +$93.9K | ﹤0.01% | 2368 |
|
|
2023
Q3 | $359K | Sell |
39,702
-16,243
| -29% | -$147K | ﹤0.01% | 2406 |
|
|
2023
Q2 | $602K | Sell |
55,945
-17,627
| -24% | -$190K | ﹤0.01% | 2278 |
|
|
2023
Q1 | $753K | Sell |
73,572
-26,129
| -26% | -$267K | ﹤0.01% | 2341 |
|
|
2022
Q4 | $1.05M | Buy |
99,701
+22,261
| +29% | +$235K | ﹤0.01% | 2393 |
|
|
2022
Q3 | $993K | Sell |
77,440
-17,546
| -18% | -$225K | ﹤0.01% | 2553 |
|
|
2022
Q2 | $1.22M | Buy |
+94,986
| New | +$1.22M | ﹤0.01% | 2586 |
|
|
2021
Q3 | – | Sell |
-60,319
| Closed | -$1.55M | – | 3650 |
|
|
2021
Q2 | $1.55M | Sell |
60,319
-3,714
| -6% | -$95.6K | ﹤0.01% | 2247 |
|
|
2021
Q1 | $2.67M | Buy |
+64,033
| New | +$2.67M | ﹤0.01% | 1689 |
|